Compile Data Set for Download or QSAR
Found 38 Enz. Inhib. hit(s) with all data for entry = 50044492
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectro...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsMore data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectro...More data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsMore data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019019(CHEMBL3288127)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 22nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsMore data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019020(CHEMBL3288126)copy SMILEScopy InChI
Affinity DataIC50: 42nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 44nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsMore data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019021(CHEMBL3288129)copy SMILEScopy InChI
Affinity DataIC50: 57nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019023(CHEMBL3288128)copy SMILEScopy InChI
Affinity DataIC50: 59nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019024(CHEMBL3288132)copy SMILEScopy InChI
Affinity DataIC50: 76nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019025(CHEMBL3288131)copy SMILEScopy InChI
Affinity DataIC50: 80nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019026(CHEMBL3288130)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019027(CHEMBL3288134)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 126nMAssay Description:Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019028(CHEMBL3288125)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019029(CHEMBL3288122)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019030(CHEMBL3288121)copy SMILEScopy InChI
Affinity DataIC50: 190nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019018(CHEMBL3288133)copy SMILEScopy InChI
Affinity DataIC50: 270nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019032(CHEMBL3288124)copy SMILEScopy InChI
Affinity DataIC50: 270nMAssay Description:Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation co...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019017(CHEMBL3288123)copy SMILEScopy InChI
Affinity DataIC50: 640nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019019(CHEMBL3288127)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+3nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50439277(CHEMBL2419490)copy SMILEScopy InChI
Affinity DataIC50: 3.20E+3nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019027(CHEMBL3288134)copy SMILEScopy InChI
Affinity DataIC50: 7.00E+3nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019026(CHEMBL3288130)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019024(CHEMBL3288132)copy SMILEScopy InChI
Affinity DataIC50: 1.03E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019021(CHEMBL3288129)copy SMILEScopy InChI
Affinity DataIC50: 1.05E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019023(CHEMBL3288128)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019020(CHEMBL3288126)copy SMILEScopy InChI
Affinity DataIC50: 1.10E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019025(CHEMBL3288131)copy SMILEScopy InChI
Affinity DataIC50: 1.15E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019029(CHEMBL3288122)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019030(CHEMBL3288121)copy SMILEScopy InChI
Affinity DataIC50: 2.80E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019018(CHEMBL3288133)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count afte...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X59CQPubMed